Mifepristone and Eribulin in combination
C1073-500
Phase 1 small_molecule completed
Quick answer
Mifepristone and Eribulin in combination for Breast Cancer is a Phase 1 program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CORCEPT THERAPEUTICS INC
- Indication
- Breast Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed